Ładuje się......
Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition
BACKGROUND: Plasma β-amyloid (Aβ) is a potential candidate for an Alzheimer’s disease (AD) biomarker because blood is an easily accessible bio-fluid, which can be collected routinely, and Aβ is one of the major hallmarks of AD pathogenesis in the brain. However, the association between plasma Aβ lev...
Zapisane w:
| Wydane w: | Alzheimers Res Ther |
|---|---|
| Główni autorzy: | , , , , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BioMed Central
2017
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5361707/ https://ncbi.nlm.nih.gov/pubmed/28330509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-017-0248-8 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|